|
1
|
McCormack AL, Thiruchelvam M, Manning-Bog
AB, et al: Environmental risk factors and Parkinson’s disease:
selective degeneration of nigral dopaminergic neurons caused by the
herbicide paraquat. Neurobiol Dis. 10:119–127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Findley L, Gresty M and Halmagyi G:
Tremor, the cogwheel phenomenon and clonus in Parkinson’s disease.
J Neurol Neurosurg Psychiatry. 44:534–546. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parsian A, Sinha R, Racette B, Zhao JH and
Perlmutter JS: Association of a variation in the promoter region of
the brain-derived neurotrophic factor gene with familial
Parkinson’s disease. Parkinsonism Relat Disord. 10:213–219. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Lau LM and Breteler MM: Epidemiology of
Parkinson’s disease. Lancet Neurol. 5:525–535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rajput A, Rozdilsky B, Ang L and Rajput A:
Significance of parkinsonian manifestations in essential tremor.
Can J Neurol Sci. 20:114–117. 1993.PubMed/NCBI
|
|
6
|
Jankovic J: Levodopa strengths and
weaknesses. Neurology. 58:S19–S32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng H, Fridkin M and Youdim MB:
Site-activated chelators derived from anti-Parkinson drug
rasagiline as a potential safer and more effective approach to the
treatment of Alzheimer’s disease. Neurochem Res. 35:2117–2123.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hashimoto T: Functional models of movement
disorders of basal ganglia origin and effects of functional
neurosurgery. Rinsho Shinkeigaku. 47:21–26. 2007.(In Japanese).
PubMed/NCBI
|
|
9
|
Wagg A: The review article by Wood et al
on nonmotor symptoms of Parkinson’s disease (PD) in the August 2010
edition of The American Journal of Geriatric Pharmacotherapy. Am J
Geriatr Pharmacother. 9:93–94. 2011. View Article : Google Scholar
|
|
10
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang C: Novel functions for small RNA
molecules. Curr Opin Mol Ther. 11:641–651. 2009.
|
|
12
|
Gehrke S, Imai Y, Sokol N and Lu B:
Pathogenic LRRK2 negatively regulates microRNA-mediated
translational repression. Nature. 466:637–641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mutez E, Larvor L, Lepretre F, et al:
Transcriptional profile of Parkinson blood mononuclear cells with
LRRK2 mutation. Neurobiol Aging. 32:1839–1848. 2011. View Article : Google Scholar
|
|
14
|
Martins M, Rosa A, Guedes LC, et al:
Convergence of miRNA expression profiling, α-synuclein interacton
and GWAS in Parkinson’s disease. PloS One. 6:e254432011. View Article : Google Scholar
|
|
15
|
Ashburner M, Ball CA, Blake JA, et al:
Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dahlquist KD, Salomonis N, Vranizan K,
Lawlor SC and Conklin BR: GenMAPP, a new tool for viewing and
analyzing microarray data on biological pathways. Nat Genet.
31:19–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu J, Li CX, Li YS, et al: MiRNA-miRNA
synergistic network: construction via co-regulating functional
modules and disease miRNA topological features. Nucleic Acids Res.
39:825–836. 2011. View Article : Google Scholar :
|
|
18
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation, and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marson A, Levine SS, Cole MF, et al:
Connecting microRNA genes to the core transcriptional regulatory
circuitry of embryonic stem cells. Cell. 134:521–533. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murchison EP, Partridge JF, Tam OH,
Cheloufi S and Hannon GJ: Characterization of Dicer-deficient
murine embryonic stem cells. Proc Natl Acad Sci USA.
102:12135–12140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hébert SS and De Strooper B: Molecular
biology. miRNAs in neurodegeneration. Science. 317:1179–1180. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anglade P, Vyas S, Javoy-Agid F, et al:
Apoptosis and autophagy in nigral neurons of patients with
Parkinson’s disease. Histol Histopathol. 12:25–31. 1997.PubMed/NCBI
|
|
23
|
Tatton WG, Chalmers-Redman R, Brown D and
Tatton N: Apoptosis in Parkinson’s disease: signals for neuronal
degradation. Ann Neurol. 53:S61–S70; discussion S70–S72. 2003.
View Article : Google Scholar
|
|
24
|
Yogev-Falach M, Amit T, Bar-Am O and
Youdim MB: The importance of propargylamine moiety in the
anti-Parkinson drug rasagiline and its derivatives in
MAPK-dependent amyloid precursor protein processing. FASEB J.
17:2325–2327. 2003.PubMed/NCBI
|
|
25
|
Sheehan JP, Swerdlow RH, Parker WD, Miller
SW, Davis RE and Tuttle JB: Altered calcium homeostasis in cells
transformed by mitochondria from individuals with Parkinson’s
disease. J Neurochem. 68:1221–1233. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bruning JC, Gautam D, Burks DJ, et al:
Role of brain insulin receptor in control of body weight and
reproduction. Science. 289:2122–2125. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fiore R, Siegel G and Schratt G: MicroRNA
function in neuronal development, plasticity and disease. Biochim
Biophys Acta. 1779:471–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Delay C, Calon F, Mathews P and Hébert SS:
Alzheimer-specific variants in the 3′UTR of Amyloid precursor
protein affect microRNA function. Mol Neurodegener. 6:702011.
View Article : Google Scholar
|
|
29
|
Padi SK, Zhang Q, Rustum YM, Morrison C
and Guo B: MicroRNA-627 mediates the epigenetic mechanisms of
vitamin D to suppress proliferation of human colorectal cancer
cells and growth of xenograft tumors in mice. Gastroenterology.
145:437–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rainer J, Ploner C, Jesacher S, et al:
Glucocorticoid-regulated microRNAs and mirtrons in acute
lymphoblastic leukemia. Leukemia. 23:746–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boren T, Xiong Y, Hakam A, et al:
MicroRNAs and their target messenger RNAs associated with ovarian
cancer response to chemotherapy. Gynecol Oncol. 113:249–255. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kumar P, Dezso Z, MacKenzie C, et al:
Circulating miRNA biomarkers for Alzheimer’s disease. PloS One.
8:e698072013. View Article : Google Scholar
|
|
33
|
Ou Z, Wada T, Gramignoli R, et al:
MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a
feedback loop of LXRα autoregulation. Mol Endocrinol. 25:584–596.
2011. View Article : Google Scholar : PubMed/NCBI
|
